Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

December 4, 2024

Study Completion Date

December 31, 2024

Conditions
Diabetes Mellitus
Interventions
DEVICE

Hybrid Closed-loop Insulin Delivery System

The Hybrid Closed-loop Insulin Delivery System system consisted of a Medtronic pump, a continuous glucose monitoring system(SIBIONICS®)and an open-source algorithm integrated into the phone. Insulin pump therapy group consisted of a Medtronic pump, and a continuous glucose monitoring system(SIBIONICS®). The difference between the two groups is that the artificial pancreas system automatically regulates the basal rate to maintain blood glucose in a target range.

DEVICE

Insulin pump

Participants used conventional insulin pumps to control blood glucose, At the same time, a continuous glucose monitoring system was used to monitor glucose changes. Health care providers adjust the insulin dose of patients according to their blood glucose level.

Trial Locations (1)

430030

Tongji Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER

NCT06295289 - Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial | Biotech Hunter | Biotech Hunter